TrialBone marrow transplantation2024
Mesenchymal stromal cell therapy for COVID-19 acute respiratory distress syndrome: a double-blind randomised controlled trial.
María E Martínez-Muñoz et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this paperpooled ittrialcites it